Skip to content
Neurolentech website

Neurolentech website

Precision Medicine for Neurodevelopmental Disorders

  • ABOUT
  • PIPELINE
  • NEWS
  • TEAM
  • CAREER
  • CONTACT

NEWS

News Press release
05 Apr, 2021

USP7 Foundation invests in Neurolentech

09 Sep, 2021

TESS Foundation invests in Neurolentech’s approach for SLC13A5

03 Aug, 2022

New clinical collaboration partner Meyer hospital Florence

08 Aug, 2022

New clinical collaboration partner University hospital Frankfurt

23 Mar, 2023

Neurolentech receives Riz up genius award 2020

events post default image
24 Apr, 2023

IST CUBE is a new investment partner

14 Jun, 2023

From diagnostic odyssey to drug discovery: TESS Research Foundation’s Collaboration with Neurolentech

22 Apr, 2024

Neurolentech Signs Technology Access Partnership with Kaerus Bioscience to Advance Neurodevelopmental Disorder Research

Precision medicine for neurodevelopmental disorders.

Registered in Austria with company number 547172F

ADDRESS

Neurolentech GMBH, Xista Science Park, Plöcking 1, 3400 Klosterneuburg, Austria

CONTACT INFO

Contact us

Registered in Austria with company number 547172F

Copyright © Neurolentech - Alle Rechte vorbehalten.

  • Privacy policy